Predicting crop yields based on climate, planting, and other variables can help regions optimize their limited resources.

Interdisciplinary team uses discrete differential geometry.

Technology capable of sampling water systems to find indicators of fecal matter contamination that are thousandths and even millionths of times smaller than those found by conventional methods is being developed by a team of researchers at Texas A&M University.

Tufts University today (May 5) announced that it has licensed a novel silk technology for the treatment of chronic skin wounds to Akeso Biomedical, Inc., an early stage medical device company. The technology was invented by David L. Kaplan, Ph.D., Stern Family Professor of Engineering at Tufts University, and his team of researchers at Tufts’ School of Engineering.

Eastern Illinois University continued its dedication to clean energy on April 25 by opening its new research facility, Center for Clean Energy Research and Education (CENCERE), dedicated to alternative fuel exploration.

For the first time, scientists have a clearer understanding of how to control the appearance of a superconducting phase in a material, adding crucial fundamental knowledge and perhaps setting the stage for advances in the field of superconductivity.

Penn researchers model neural structures on the smallest scales to better understand traumatic brain injury.

Sandia project to fill gaps by linking atomic structure with how parts perform.

Compounds can be 70 times more potent than Tenofovir, a first-line HIV regimen

More than a mile beneath the ocean's surface, as dark clouds of mineral-rich water billow from seafloor hot springs called hydrothermal vents, unseen armies of viruses and bacteria wage war.

Many believe teen mothers have an enviable quality of life, a high income and involved fathers.

NYU Langone Medical Center has established a new drug discovery accelerator, the Office of Therapeutics Alliances (OTA). OTA is an innovative, nimble program that advances the discovery of novel therapeutic projects by combining the scientific strengths of NYU Langone investigators in dissecting disease pathways with the expertise of external professional drug discovery and development partners in the biopharma industry.